4//SEC Filing
Ordonez Claudia 4
Accession 0001209191-21-032361
CIK 0001664710other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:37 PM ET
Size
8.9 KB
Accession
0001209191-21-032361
Insider Transaction Report
Form 4
Ordonez Claudia
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-11$0.48/sh+1,000$480→ 1,000 total - Sale
Common Stock
2021-05-11$50.15/sh−1,000$50,150→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-05-11−1,000→ 99,211 totalExercise: $0.48Exp: 2029-09-18→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]One-quarter (1/4th) of the shares subject to the option shall vest on September 16, 2020, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001808290
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:37 PM ET
- Size
- 8.9 KB